SIC
SLS icon

SJS Investment Consulting’s SELLAS Life Sciences SLS Stock Holding History

SJS Investment Consulting’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$590K Buy
40,000
+15,000
+60% +$104K 0.06% 83
2026
Q1 		$106K Buy
+25,000
New +$112K 0.01% 210

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
FWA
Fulcrum Wealth Advisors Bellevue, Washington $131M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
VH
Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $531M AUM 27.28% 1-Year Est. Return

SJS Investment Consulting's SLS Position: Q2 2026 in Review

SJS Investment Consulting increased its SELLAS Life Sciences (SLS) stake by 60% in Q2 2026, buying an estimated $104K and bringing the position to 40,000 shares worth $590K. The position accounts for 0.06% of the portfolio, ranked #83.

SJS Investment Consulting first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • SJS Investment Consulting held 40,000 shares of SELLAS Life Sciences worth $590K as of Q2 2026.
  • SJS Investment Consulting bought 15,000 SELLAS Life Sciences shares in Q2 2026, an estimated $104K.
  • SELLAS Life Sciences made up 0.06% of SJS Investment Consulting's portfolio in Q2 2026, its #83 holding.
  • SJS Investment Consulting first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.